Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Clinical Trials, Standards & Regulation, Small Molecules

Time for Pharma to Deliver?

The adequate inclusion of women in clinical trials is an issue with an increasing level of awareness – and it’s a topic The Medicine Maker has covered previously (1)(2). But there is one particular group of women who continue to be far more underserved by clinical research: pregnant women.

And there’s a good reason the problem should not be ignored: according to the FDA, half of pregnant women report taking at least one medicine (3). Worrying then that, of the 172 drugs approved by the FDA between 2000 and 2010, 97 percent had an “undetermined” risk for pregnancy. Perhaps worse, for 73 percent of new drugs the amount of data available on safety in pregnancy was rated as “none” (4). Every day, pregnant women need to make decisions and balance the risks to their own and their unborn children’s health when deciding to take – or not to take – medications for which no clear guidance is available. Often, the health care professionals advising them can’t offer much help either, for the same reason: the data they need simply doesn’t exist.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login as a Guest or via Social Media

About the Author

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as a Deputy Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Related Articles

Business & Regulation

Crossing the Rubicon

| Maryam Mahdi

Discovery & Development

How Transparent Are Trials?

| Stephanie Sutton

Manufacture

A Tall Task

| Roisin McGuigan

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker